Cargando…

Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?

BACKGROUND: Neuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD). In-depth neuropsychological assessment revealed specific dysfunctions in the two dementia syndromes. However, a significant ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Reul, Sophia, Lohmann, Hubertus, Wiendl, Heinz, Duning, Thomas, Johnen, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550986/
https://www.ncbi.nlm.nih.gov/pubmed/28793933
http://dx.doi.org/10.1186/s13195-017-0287-1
_version_ 1783256222601838592
author Reul, Sophia
Lohmann, Hubertus
Wiendl, Heinz
Duning, Thomas
Johnen, Andreas
author_facet Reul, Sophia
Lohmann, Hubertus
Wiendl, Heinz
Duning, Thomas
Johnen, Andreas
author_sort Reul, Sophia
collection PubMed
description BACKGROUND: Neuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD). In-depth neuropsychological assessment revealed specific dysfunctions in the two dementia syndromes. However, a significant overlap of cognitive impairments exists in early disease stages. We questioned whether a standard neuropsychological assessment at initial clinical presentation can delineate patients with AD versus bvFTD. METHODS: In a retrospective approach, we evaluated and compared how cognitive profiles assessed at initial clinical presentation predicted the diagnosis of later verified AD (n = 43) and bvFTD (n = 26). Additionally, the neuropsychological standard domains memory, language, visuospatial skills, executive functions, praxis and social cognition were subjected to stepwise discriminant analysis to compare their differential contribution to diagnosis. RESULTS: Regardless of diagnosis, a percentage of patients presented with major deterioration in a wide range of cognitive domains when compared with age-matched normative data. Only few significant differences were detected on the group level: Patients with AD were relatively more impaired in the verbal recall, verbal recognition, figure copy, and surprisingly in the executive subdomains, set shifting and processing speed whereas bvFTD was characterised by more deficits in imitation of face postures. A combination of tests for verbal recall, imitation of limb and face postures, and figure copy showed the greatest discriminatory power. CONCLUSIONS: Our results imply that the contribution of a standard neuropsychological assessment is limited for differential diagnosis of AD and bvFTD at initial presentation. In contrast to current clinical guidelines, executive functions are neither particularly nor exclusively impaired in patients with bvFTD when assessed within a standard clinical neuropsychological test battery. The significant overlap of bvFTD and AD concerning the profile of cognitive impairments questions current neuropsychological diagnostic criteria and calls for revision, regarding both the degree and the profile of cognitive deficits.
format Online
Article
Text
id pubmed-5550986
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55509862017-08-14 Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation? Reul, Sophia Lohmann, Hubertus Wiendl, Heinz Duning, Thomas Johnen, Andreas Alzheimers Res Ther Research BACKGROUND: Neuropsychological testing is considered crucial for differential diagnosis of Alzheimer’s disease (AD) and behavioural variant frontotemporal dementia (bvFTD). In-depth neuropsychological assessment revealed specific dysfunctions in the two dementia syndromes. However, a significant overlap of cognitive impairments exists in early disease stages. We questioned whether a standard neuropsychological assessment at initial clinical presentation can delineate patients with AD versus bvFTD. METHODS: In a retrospective approach, we evaluated and compared how cognitive profiles assessed at initial clinical presentation predicted the diagnosis of later verified AD (n = 43) and bvFTD (n = 26). Additionally, the neuropsychological standard domains memory, language, visuospatial skills, executive functions, praxis and social cognition were subjected to stepwise discriminant analysis to compare their differential contribution to diagnosis. RESULTS: Regardless of diagnosis, a percentage of patients presented with major deterioration in a wide range of cognitive domains when compared with age-matched normative data. Only few significant differences were detected on the group level: Patients with AD were relatively more impaired in the verbal recall, verbal recognition, figure copy, and surprisingly in the executive subdomains, set shifting and processing speed whereas bvFTD was characterised by more deficits in imitation of face postures. A combination of tests for verbal recall, imitation of limb and face postures, and figure copy showed the greatest discriminatory power. CONCLUSIONS: Our results imply that the contribution of a standard neuropsychological assessment is limited for differential diagnosis of AD and bvFTD at initial presentation. In contrast to current clinical guidelines, executive functions are neither particularly nor exclusively impaired in patients with bvFTD when assessed within a standard clinical neuropsychological test battery. The significant overlap of bvFTD and AD concerning the profile of cognitive impairments questions current neuropsychological diagnostic criteria and calls for revision, regarding both the degree and the profile of cognitive deficits. BioMed Central 2017-08-09 /pmc/articles/PMC5550986/ /pubmed/28793933 http://dx.doi.org/10.1186/s13195-017-0287-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Reul, Sophia
Lohmann, Hubertus
Wiendl, Heinz
Duning, Thomas
Johnen, Andreas
Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title_full Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title_fullStr Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title_full_unstemmed Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title_short Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
title_sort can cognitive assessment really discriminate early stages of alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550986/
https://www.ncbi.nlm.nih.gov/pubmed/28793933
http://dx.doi.org/10.1186/s13195-017-0287-1
work_keys_str_mv AT reulsophia cancognitiveassessmentreallydiscriminateearlystagesofalzheimersandbehaviouralvariantfrontotemporaldementiaatinitialclinicalpresentation
AT lohmannhubertus cancognitiveassessmentreallydiscriminateearlystagesofalzheimersandbehaviouralvariantfrontotemporaldementiaatinitialclinicalpresentation
AT wiendlheinz cancognitiveassessmentreallydiscriminateearlystagesofalzheimersandbehaviouralvariantfrontotemporaldementiaatinitialclinicalpresentation
AT duningthomas cancognitiveassessmentreallydiscriminateearlystagesofalzheimersandbehaviouralvariantfrontotemporaldementiaatinitialclinicalpresentation
AT johnenandreas cancognitiveassessmentreallydiscriminateearlystagesofalzheimersandbehaviouralvariantfrontotemporaldementiaatinitialclinicalpresentation